| 期 |
栏目 |
标题 |
文件 |
| 卷 66, 编号 4 (2017) |
Articles |
Pathogenetic justification of possibility of antidiuretic hormone use in incontinent women |
(Rus)
|
| 卷 66, 编号 5 (2017) |
Articles |
Treatment of infertility in women with polycystic ovary syndrome using assisted reproductive technology |
(Rus)
|
| 卷 67, 编号 1 (2018) |
Articles |
Experience of cyclooxygenase inhibitor use for correction of urine overproduction in incontinent women |
(Rus)
|
| 卷 67, 编号 1 (2018) |
Articles |
A preimplantation genetic testing of monogenic diseases. Description of clinical case |
(Rus)
|
| 卷 67, 编号 2 (2018) |
Articles |
Composition of endometrial microbiota and chronic endometritis severity in patients with in vitro fertilization failures. Is there any connection? |
(Rus)
|
| 卷 67, 编号 2 (2018) |
Articles |
The effect of excess body weight and obesity on the effectiveness of assisted reproductive technologies programs |
(Rus)
|
| 卷 67, 编号 2 (2018) |
Articles |
Clinical efficiency of desmopressin and cyclooxygenase inhibitor use in incontinent women |
(Rus)
|
| 卷 67, 编号 2 (2018) |
Articles |
Ovarian aromatase activity: evaluation methods and the clinical significance in IVF protocols |
(Rus)
|
| 卷 68, 编号 1 (2019) |
Reviews |
Granulocyte colony-stimulating factor as a checkpoint of the embryo invasive potential and endometrial receptivity |
(Rus)
|
| 卷 68, 编号 4 (2019) |
Reviews |
The efficiency of IVF/ICSI protocols in female subclinical hypothyroidism and thyroid autoimmunity |
(Rus)
(Eng)
|
| 卷 68, 编号 2 (2019) |
Reviews |
Womenʼs professional sports: reproductive health, hormonal contraception, doping issues |
(Rus)
(Eng)
|
| 卷 68, 编号 5 (2019) |
Reviews |
Inhibin as a reproductive biomarker part 2. Clinical significance of inhibins in reproductive medicine |
(Rus)
|
| 卷 68, 编号 6 (2019) |
Original Research |
Use of androgens and aromatase inhibitors in poor responders undergoing in vitro fertilization |
(Rus)
|
| 卷 68, 编号 6 (2019) |
Current public health problems |
Predictive value of ovarian hormone-producing function assessment in poor responders undergoing assisted reproductive technologies |
(Rus)
|
| 卷 69, 编号 4 (2020) |
Reviews |
Current views on overweight and obesity influence on assisted reproductive technology data |
|
| 卷 69, 编号 3 (2020) |
Original Research |
育龄妇女食饵性肥胖治疗对卵巢瘦素水平及激素功能的影响 |
(Rus)
(Eng)
(简体中)
|
| 卷 69, 编号 6 (2020) |
Original Research |
Suboptimal response to controlled ovarian stimulation in IVF / ICSI cycles |
|
| 卷 69, 编号 5 (2020) |
Original Research |
Blood serum and follicular fluid relaxin: a pilot study of the hormone effects on ovarian function and fertilization efficiency |
(Rus)
(Eng)
|
| 卷 70, 编号 1 (2021) |
Original Research |
Main characteristics of IVF / ICSI protocols in patients with suboptimal response to controlled ovarian stimulation |
(Rus)
(Eng)
|
| 卷 71, 编号 2 (2022) |
Original Research |
Mesenchymal stromal cells application for experimental genital tuberculosis combination therapy |
(Rus)
(Eng)
|
| 卷 71, 编号 5 (2022) |
Original Research |
Issues in reproductive health in chromosome translocation carriers |
|
| 卷 72, 编号 1 (2023) |
Original Research |
The influence of reproductively significant autoantibodies determined in the follicular fluid on the quality of the obtained oocytes and embryos, as well as on the implantation rate in assisted reproductive technology cycles |
|
| 卷 72, 编号 4 (2023) |
Original Research |
Endometrial blood flow evaluation in women with uterine fibroids during in vitro fertilization treatment |
(Rus)
|
| 卷 72, 编号 6 (2023) |
Original Research |
DNA-fragmented sperm ability to bind to the zona pellucida |
|
| 卷 72, 编号 6 (2023) |
Original Research |
Endometrial NK cells in repeated implantation failure – quantity and functional markers |
|
| 卷 72, 编号 6 (2023) |
Original Research |
Development and testing of an endometrial status assessment test based on RNAampliSeq technology |
|
| 卷 73, 编号 3 (2024) |
Original Research |
Assessment of endometrial and subendometrial three-dimensional power Doppler angiography evaluated by the VOCAL method in frozen-thawed embryo transfer cycles on hormone replacement therapy |
|
